Clinical Trials Browser

Phase 3 × cc-486 × Other hematologic neoplasm × Clear all

NCT01757535 2025-07-08

QUAZAR AML-001

Phase 3 Completed

472 enrolled 24 charts 2 FDA

Other hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Acute

NCT04173533 2024-05-14

AMADEUS

Phase 3 Active not recruiting

Classical hematologyOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute